Lexicon Pharmaceuticals LXRX Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's proceeds from issuance of shares under incentive and share based compensation plans including stock options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's proceeds from issuance of shares under incentive and share based compensation plans including stock options?
- Lexicon Pharmaceuticals (LXRX) reported proceeds from issuance of shares under incentive and share based compensation plans including stock options of $65K in Q1 2026.
- What does proceeds from issuance of shares under incentive and share based compensation plans including stock options mean?
- Refers to cash received from employees or directors upon the exercise of stock options or the purchase of shares under employee stock purchase plans. It indicates the level of participation in equity-based compensation programs.